《港股開市》恆指高開48點 藥明生物及阿裏造好
美國股市昨晚(23日)個別發展,納斯達克指數創收市新高。恆指今早高開48點或0.2%,報28,865;國指高開14點或0.1%,報10,688。恆生科技指數高開25點或0.3%,報8,045。
友邦保險(01299.HK)、匯控(00005.HK)、中移動(00941.HK)分別高開0.7%、低開0.9%、低開0.4%。內銀股偏軟,工行(01398.HK)、建行(00939.HK)低開0.2%及0.3%。
市傳螞蟻擬與國企成立信用評分公司,最快今年第三季成立,阿裏巴巴(09988.HK)高開1.2%。
騰訊(00700.HK)、美團(03690.HK)分別高開0.3%及0.6%。丘鈦科技(01478.HK)附屬崑山丘鈦已提交上市申請,該股開市升2.9%。
藍籌醫藥股個別發展,石藥(01093.HK)低開1.6%;藥明生物(02269.HK)高開2.4%。波司登(03998.HK)全年純利17億人民幣增42%,該股開市微跌0.8%。
東方錶行集團(00398.HK)全年純利按年增逾1.3倍至2.3億元,派每股末期及特別息共39仙,該股開市升1.1%。優品360(02360.HK)全年純利8,145萬增5.7倍,該股開市升4.6%。
南岸集團(00577.HK)澳門附屬申請自願清盤,股價挫12%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.